UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Search Filters
Format Format
Format Format
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20329) 20329
Dissertation (128) 128
Book Chapter (118) 118
Publication (34) 34
Government Document (21) 21
Conference Proceeding (13) 13
Book / eBook (5) 5
Magazine Article (3) 3
Newspaper Article (2) 2
Web Resource (2) 2
Book Review (1) 1
Subjects Subjects
Subjects Subjects
Sort by Item Count (A-Z)
Filter by Count
science & technology (15412) 15412
life sciences & biomedicine (14150) 14150
animals (11792) 11792
humans (10939) 10939
phosphorylation (7061) 7061
src-family kinases - metabolism (6274) 6274
biochemistry & molecular biology (6146) 6146
mice (6018) 6018
signal transduction (5489) 5489
cell biology (4899) 4899
biological and medical sciences (3600) 3600
src homology domains (3233) 3233
protein-tyrosine kinases - metabolism (3065) 3065
cell line (2896) 2896
oncology (2763) 2763
rats (2708) 2708
cells, cultured (2643) 2643
amino acid sequence (2568) 2568
molecular sequence data (2498) 2498
src (2418) 2418
proteins (2390) 2390
protein binding (2380) 2380
fundamental and applied biological sciences. psychology (2208) 2208
cell line, tumor (2187) 2187
male (2144) 2144
female (2085) 2085
tyrosine - metabolism (1985) 1985
enzyme activation (1932) 1932
src-family kinases - antagonists & inhibitors (1862) 1862
kinases (1824) 1824
tyrosine (1728) 1728
transfection (1702) 1702
medical sciences (1665) 1665
research (1612) 1612
research article (1581) 1581
signal transduction - physiology (1542) 1542
signal transduction - drug effects (1538) 1538
src-family kinases - genetics (1527) 1527
binding sites (1458) 1458
src-family kinases (1427) 1427
mutation (1408) 1408
proto-oncogene proteins - metabolism (1408) 1408
adaptor proteins, signal transducing (1388) 1388
proto-oncogene proteins pp60 - metabolism (1345) 1345
src protein (1315) 1315
immunology (1237) 1237
enzyme inhibitors - pharmacology (1198) 1198
science & technology - other topics (1173) 1173
molecular and cellular biology (1170) 1170
multidisciplinary sciences (1162) 1162
gene expression (1137) 1137
phosphoproteins - metabolism (1132) 1132
apoptosis (1131) 1131
proteins - metabolism (1123) 1123
cancer (1113) 1113
blotting, western (1112) 1112
abridged index medicus (1087) 1087
phosphorylation - drug effects (1083) 1083
phosphatidylinositol 3-kinases - metabolism (1079) 1079
tumors (1078) 1078
biophysics (1029) 1029
tumor cells, cultured (1021) 1021
protein-tyrosine kinases - genetics (948) 948
mice, knockout (938) 938
cell physiology (933) 933
physiological aspects (923) 923
analysis (921) 921
models, biological (912) 912
protein structure, tertiary (912) 912
cell proliferation (908) 908
genetics & heredity (908) 908
src-family kinases - physiology (905) 905
mice, inbred c57bl (899) 899
pyrimidines - pharmacology (898) 898
models, molecular (896) 896
protein kinase inhibitors - pharmacology (891) 891
base sequence (846) 846
ligands (835) 835
recombinant fusion proteins - metabolism (819) 819
src homology 2 domain-containing, transforming protein 1 (816) 816
kinetics (812) 812
intracellular signaling peptides and proteins (805) 805
time factors (803) 803
pharmacology & pharmacy (787) 787
mitogen-activated protein kinases - metabolism (783) 783
phosphotyrosine - metabolism (765) 765
neurosciences (762) 762
cell adhesion (760) 760
hematology (748) 748
neurosciences & neurology (746) 746
receptor, epidermal growth factor - metabolism (720) 720
3t3 cells (719) 719
genetic aspects (701) 701
enzyme activation - drug effects (697) 697
shc signaling adaptor proteins (687) 687
phosphotransferases (668) 668
rats, sprague-dawley (662) 662
cell movement (654) 654
biology (649) 649
dose-response relationship, drug (626) 626
Library Location Library Location
Language Language
Language Language
Sort by Item Count (A-Z)
Filter by Count
English (20398) 20398
Chinese (168) 168
Japanese (133) 133
French (48) 48
Russian (29) 29
German (16) 16
Korean (11) 11
Czech (7) 7
Portuguese (6) 6
Norwegian (4) 4
Spanish (4) 4
Polish (3) 3
Ukrainian (2) 2
Hungarian (1) 1
Latin (1) 1
Persian (1) 1
Swedish (1) 1
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range

Biochemical journal, ISSN 0264-6021, 12/2007, Volume 408, Issue 3, pp. 297 - 315
Drug discovery | Kinase profiling | Protein kinase | Anti-cancer drugs | Inhibitor specificity | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Amino Acid Sequence | Cell Line | Phosphorylation | Recombinant Proteins - antagonists & inhibitors | Animals | Mitogen-Activated Protein Kinases - antagonists & inhibitors | Humans | Drug Design | Protein Kinase Inhibitors - pharmacology | Enzyme Activation | Mitogen-Activated Protein Kinases - metabolism | Spodoptera | Index Medicus | Yes1, Yamaguchi sarcoma viral oncogene homologue 1 | CSK, C-terminal Src kinase | Lck, lymphocyte cell-specific protein-tyrosine kinase | EGF, epidermal growth factor | FGF-R, fibroblast-growth-factor receptor | PAK, p21-activated protein kinase | PDK, 3-phosphoinositide-dependent protein kinase | PI3K, phosphatidylinositol (phosphoinositide) 3-kinase | NEK, NIMA (never in mitosis in Aspergillus nidulans)-related kinase | RSK, p90 ribosomal S6 kinase | HEK-293 cells, human embryonic kidney-293 cells | VEGF, vascular endothelial growth factor (vasoendothelial growth factor) | EF2K, elongation-factor-2 kinase | CK, casein kinase | PTEN, phosphatase and tensin homologue deleted on chromosome 10 | ERK, extracellular-signal-regulated kinase | ATM, ataxia telangiectasia mutated | drug discovery | SRPK, serine-arginine protein kinase | IL-1, interleukin 1 | MNK, MAPK-integrating protein kinase | ROCK, Rho-dependent protein kinase | CaMKK, CaMK kinase | GST, glutathione transferase | MKK1, MAPK kinase-1 (also called MEK1, MAPK or ERK kinase 1) | GAK, cyclin G-associated kinase | inhibitor specificity | FMK, fluoromethylketone | MST, mammalian homologue Ste20-like kinase | PKA, cAMP-dependent protein kinase | FKBP, FK506-binding protein | PPAR, peroxisome-proliferator-activated receptor | IKK, inhibitory κB kinase | PH, pleckstrin homology | MBP, myelin basic protein | AICAR, aminoimidazole-4-carboxamide-1-β-D-ribofuranoside | MAPKAP-K, MAPK-activated protein kinase | Sf21, Spodoptera frugiperda (fall armyworm) 21 | MARK, microtubule-affinity-regulating kinase | PIM, provirus integration site for Moloney murine leukaemia virus | LPS, lipopolysaccharide | MSK, mitogen- and stress-activated protein kinase | anti-cancer drugs | MAPK, mitogen-activated protein kinase | MELK, maternal embryonic leucine-zipper kinase | His6, hexahistidine | CAK, cyclin-dependent kinase-activating kinase | Eph-A2, Ephrin A2 receptor | PLK, polo-like kinase | ATF2, activating transcription factor 2 | PKD, protein kinase D | Src, sarcoma kinase | AMPK, AMP-activated protein kinase | MMS, methyl methanesulfonate | CHK, checkpoint kinase | JNK, c-Jun N-terminal kinase | TORC1, mTOR (mammalian target of rapamycin)–raptor (regulatory associated protein of mTOR) complex | protein kinase | BRSK, brain-specific kinase | RIP2, receptor-interacting protein 2 | kinase profiling | IGF-1, insulin-like growth factor-1 | S6K1, S6 kinase 1 | DYRK, dual-specificity tyrosine-phosphorylated and -regulated kinase | HIPK, homeodomain-interacting protein kinase | ZMP, aminoimidazole-4-carboxamide-1-β-D-ribofuranoside monophosphate | PRAK, p38-regulated activated kinase | PKC, protein kinase C | Src-I1, Src inhibitor 1 | TANK, TRAF (tumour-necrosis-factor-receptor-associated factor)-family-member-associated nuclear factor κB activator | NFAT, nuclear factor for activated T-cells | PHK, phosphorylase kinase | GSK3, glycogen synthase kinase 3 | PKB, protein kinase B (also called Akt) | CaMK, calmodulin-dependent kinase | CDK, cyclin-dependent protein kinase | NDRG, N-myc downstream-regulated gene | SmMLCK, smooth-muscle myosin light-chain kinase | TBK1, TANK-binding kinase 1 | PRK, protein kinase C-related kinase | SGK, serum- and glucocorticoid-induced kinase
Journal Article
FEBS letters, ISSN 0014-5793, 2001, Volume 496, Issue 1, pp. 44 - 48
Casein kinase | Inhibitor | Casein kinase-2 | Protein phosphorylation | Protein kinase | nCK, native casein kinase | OA, okadaic acid | PRAK, p38-regulated/activated kinase | CSK, C-terminal Src kinase | AMPK, AMP-activated protein kinase | CHK, checkpoint kinase | JNK, c-Jun N-terminal kinase | MAPKAP, MAPK-activated protein kinase | p70S6K, p70 ribosomal protein S6 kinase | CK, casein kinase | SAPK, stress-activated protein kinase | PDK, 3-phosphoinositide-dependent kinase | ROCK, Rho-dependent protein kinase | CDK, cyclin-dependent kinase | G-CK, Golgi casein kinase | PKC, protein kinase C | MKK, MAPK kinase (also called MEK) | PKA, cAMP-dependent protein kinase | DRB, 1-(β-D-ribofuranosyl)-5,6-dichlorobenzimidazole | PHK, phosphorylase kinase | GSK3, glycogen synthase kinase 3 | PKB, protein kinase B (also called Akt) | rCK, recombinant casein kinase | ERK, extracellular signal-regulated kinase | HS1, hematopoietic lineage cell-specific protein 1 | MSK, mitogen- and stress-activated protein kinase | TBB, 4,5,6,7-tetrabromo-2-azabenzimidazole or 4,5,6,7-tetrabromobenzotriazole | MAPK, mitogen-activated protein kinase | SGK, serum- and glucocorticoid-induced kinase | Biochemistry & Molecular Biology | Biophysics | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Protein Kinases - metabolism | Jurkat Cells - cytology | Protein Kinases - drug effects | Casein Kinase II | Emodin - pharmacology | Jurkat Cells - metabolism | Humans | Enzyme Inhibitors - pharmacology | Protein-Serine-Threonine Kinases - genetics | Substrate Specificity | Adenosine Triphosphate | Binding Sites - genetics | Binding, Competitive - drug effects | Triazoles - pharmacology | Triazoles - metabolism | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Binding Sites - drug effects | Protein-Serine-Threonine Kinases - metabolism | Staurosporine - pharmacology | Amino Acid Substitution | Jurkat Cells - drug effects | Index Medicus
Journal Article
Biomedical Journal, ISSN 2319-4170, 05/2013, Volume 36, Issue 3, pp. 106 - 117
Hsp90 | conformational cycle | clients | posttranslational modifications | ATPase | co-chaperones | Animals | HSP90 Heat-Shock Proteins - antagonists & inhibitors | HSP90 Heat-Shock Proteins - physiology | Humans | HSP90 Heat-Shock Proteins - chemistry | Protein Conformation | Protein Processing, Post-Translational | Molecular Chaperones - physiology | Signal transduction | Antibiotics | Protein folding | Breast cancer | Kinases | Machinery | Binding sites | Index Medicus | Hsp90 can be secreted as well and it promotes tumor invasiveness. Blocking the secreted Hsp90 led to a significant inhibition of tumor metastasis. Structure of Hsp90 Top Structurally | nucleotide binding is not the only determinant for Hsp90 conformation. The interaction with co-chaperones and client protein also influences the conformational rearrangement of Hsp90. | p23/Sba1 | eNOS | in which the ATP lid is closed but the N-domains are still open. The N-terminal dimerization leads to the formation of the second intermediate state (I2) | while Hsp90β is constitutively expressed. Hsp90 analogues also exist in other cellular compartments such as Grp94 in the endoplasmic reticulum | the M-domain contributes to the interaction sites for client proteins and some co-chaperones. The C-domain is essential for the dimerization of Hsp90. Interestingly | Hsp90 works together with a large group of cofactors | the activation of its client protein | MutL (GHKL) domain ATPases | Therefore | Binding of Aha1 induces a partially closed Hsp90 conformation and accelerates the progression of the ATPase cycle dramatically. | Different from other well-known molecular chaperone like Hsp70 and GroEL/ES | Interestingly | 113 | which acts as a core modulator in plant immunity. During the recruitment and activation of NLRs | more than 200 Hsp90 client proteins have been identified (see http://www.picard.ch/downloads/Hsp90interactors.pdf ). Besides the well-studied clients such as protein kinases and SHRs | 115 | termed co-chaperones. Co-chaperones form defined binary or ternary complexes with Hsp90 | 116 | Our understanding of the Hsp90 machinery has been greatly advanced by research of the last decades. However | 118 | Function and Regulation of the Hsp90 Machinery. Biomed J 2013;36:106-17 How to cite this URL: Li J | leading to an asymmetric intermediate complex. Hsp90 adopts the ATPase-active (closed) conformation after binding of ATP. p23/Sba1 stabilizes the closed state of Hsp90 | and protein degradation. Interestingly | the lid segment is very flexible | and the NLR protein may dissociate from Hsp90. Hsp90 complexes in RNA processing Recent studies showed that Hsp90 is also involved in the assembly of small nucleolar ribonucleoproteins (snoRNPs) and RNA polymerase. | 15 | the lid segment promotes ATP hydrolysis. Once ATP is hydrolyzed | with 1 min–1 for yeast Hsp90 and 0.1 min–1 for human Hsp90. | hyperphosphorylation also leads to a decreased Hsp90 activity. In yeast | although a TPR domain is present in Sgt1 as well | California | Germany Date of Submission 05-Sep-2012 Date of Acceptance 02-Nov-2012 Date of Web Publication 10-Jun-2013 Correspondence Address: Johannes Buchner Center for Integrated Protein Science | the M-domain in blue | which weakens the binding of Hop/Sti1 and promotes its exit from the complex. Potentially another PPIase (dashed line) associates to form the "late complex" together with Hsp90 and p23/Sba1. After the hydrolysis of ATP | posttranslational modifications of Hsp90 | and protein degradation | 125 | 5 | the protein phosphatase PP5 (yeast homologue Ppt1) | 6 | in eukaryotic Hsp90 | such as mitochondrial/chloroplast protein import (Tom70/Toc64) | 9 | In Ppt1 knockout strains | posttranslational modifications How to cite this article: Li J | Hsp90 is a homodimer and each protomer contains three flexibly linked regions | p23 is a conformation-specific co-chaperone which binds exclusively to the closed conformation of Hsp90. | 24 | viral infection | 27 | Fkbp51 | They regulate the function of Hsp90 in different ways such as inhibition and activation of the ATPase of Hsp90 as well as recruitment of specific client proteins to the cycle. Interestingly | such as double-stranded DNA protein kinase | in which the ATP lid is closed but the N-domains are still open. Then | 132 | one of the most abundant and conserved molecular chaperones | and the C-domain in orange. Click here to view Conformational dynamics of Hsp90 Top Hsp90 is a weak ATPase and the turnover rates are very low | After fast ATP binding | Hsp90 adopts a "V"- shaped form | 35 | the maturation of protein kinases also requires the Hsp70 chaperone machinery [Figure 3]B. In the early stage | Research on the assembly of Hsp90 with SHRs had shown that several distinct complexes are formed during the maturation processes. | phosphorylation affects the conformational cycle of Hsp90 | Hsp90 stabilizes and promotes the correct folding of its client proteins | recent results imply that p53 may be destabilized by Hsp90 | and ch-Hsp90 in the chloroplast. | Chaperone cycle for protein kinases Similar to SHRs | 40 | 43 | the potentiation effects do not strictly depend on the PPIase activity of Fkbp52 as PPIase-deficient mutants are also able to potentiate GR transactivation | Technical University of Munich. Lichtenbergstrasse 4 | Notably | Nucleotide binding induces directionality and a conformational cycle. | 49 | similar heterocomplexes can be found from yeast to man even in the absence of client protein. Recent studies [using FRET | PPIase | Pih1 | co-chaperone interaction | Click here to view optimized website for mobile devices Journal is indexed with MEDLINE/Index Medicus and PubMed Share on facebookShare on twitter Share on citeulike Share on googleShare on linkedin More Sharing Services Table of Contents REVIEW ARTICLE Year : 2013 | Volume : 36 | Issue : 3 | Page : 106-117 Structure | while c-Src is largely independent of Hsp90. Notably | which implies that the tight regulation of the Hsp90 phosphorylation state is necessary for the efficient processing of client proteins. Chaperone cycle for nucleotide-binding site and leucine-rich repeat domain containing (NLR) proteins NLRs are conserved immune sensors which recognize pathogens. Accumulating evidence indicates that Hsp90 and its co-chaperones Sgt1 and Rar1 are involved in the maturation of these proteins. Sgt1 interacts with the N-domain of Hsp90 through its CS domain | acetylation | It is reasonable to assume that Hsp90 recognizes certain conformations or the stability of the client protein rather than its primary sequence. Src kinase is a prominent example here. The v-Src and its cellular counterpart (c-Src) share 95% sequence identity but distinct Hsp90 dependency. The activation of v-Src strictly depends on Hsp90 | Technische Universität München | The maturation of most SHRs strictly depends on the interaction with Hsp90. Co-chaperones such as Hop/Sti1 and the large peptidylprolyl isomerase (PPIase) have strong influences on the activation. | and the NLR protein may dissociate from Hsp90. (D) Hsp90-R2TP complex. Model of the R2TP complex in yeast. Pih1 interacts with Rvb1/2 | the phosphorylation states of Hsp90 must be precisely regulated in order to maintain the proper function of Hsp90. In addition | Hsp90 reaches a more compact state | provide another level of regulation. They influence the conformational cycle | in which first one Hop/Sti1 binds to the Hsp90 dimer and stabilizes its open conformation. As a result | 59 | was also reduced consistent with the notion thatHsp90 acts as an NO sensor. This provides a feedback mechanism to inhibit further eNOS activation. Nitrosylation or mutation of the modified C-terminal cysteine residue in Hsp90 led to an ATPase-incompetent state in which the N-terminal domains are kept in the open conformation. The result indicates that nitrosylation has a profound impact on the inter-domain communication in the Hsp90 dimer. Hsp90 client protein recognition Top To date | phosphorylation also modulates the interaction with co-chaperones and thus exerts further influence on the Hsp90 machinery. For example | PDB 2CG9). The N-domain is depicted in green | Rar1 | together with Hsp90 and a PPIase. It facilitates the maturation of client proteins by stabilizing the closed conformation of Hsp90. As a result | it is indispensable for maintaining the hormone binding activity of the glucocorticoid receptor (GR) and progesterone receptor (PR). | Aha1 is the most powerful ATPase activator of Hsp90. It binds the N- and M-domains of Hsp90. | tyrosine phosphorylation on Hsp90 disrupts the interaction with Cdc37 and promotes the recruitment of Aha1. C-terminal phosphorylation of Hsp90 regulates alternate binding to co-chaperones Chip and Hop | is partially inhibited in the presence of p23/Sba1. | which facilitate the maturation of client proteins. In addition | a new model of the chaperone cycle emerges [Figure 3]A | and Hsp90 returns to the open conformation again. Figure 2: Conformational cycle of Hsp90. After fast ATP binding | c-Src kinase | and NMR-based approaches suggested that for heat-treated p53 | more than 20 co-chaperones have been identified. | we just start to understand their contributions to client protein activation. Regulation of Hsp90 by posttranslational modifications Top Posttranslational modifications are another important regulatory element of the Hsp90 machinery. Different posttranslational modifications such as phosphorylation | which is indispensable for the release of the client protein | 60 | Hsp90 and the R2TP complex are involved in the biogenesis and assembly of snoRNPs. Notably | activation | Hsp90 and Sgt1 form a ternary complex with the co-chaperone Rar1 | proposed that Hsp90-bound p53 is in a molten globule state. In contrast | while bacteria possess an Hsp90 protein | Buchner J. Structure | such as phosphorylation and acetylation | and methylation tightly control the function of Hsp90 and thus influence the maturation of client proteins. Phosphorylation Phosphorylation is the most frequently detected posttranslational modification of Hsp90. A number of different tyrosine or serine phosphorylation sites have been identified and investigated for their impact on Hsp90's chaperone function. For example | the so-called Gyrase | which determine cellular protein folding/degradation balances. Furthermore | as it contains crucial catalytic residues for forming the composite ATPase site. Moreover | According to reconstitution experiments | and the AAA+ ATPase Rvb1 and Rvb2) has been extensively investigated [Figure 3]D. | general flexibility | In yeast | Department of Chemistry | strongly influences the binding between Hsp90 and its client protein. In general | intracellular transport | Function and Regulation of the Hsp90 Machinery. Biomed J [serial online] 2013 [cited 2014 Dec 31];36:106-17. Available from: http://www.biomedj.org/text.asp?2013/36/3/106/113230 Heat shock protein 90 (Hsp90) | a middle domain (M-domain) | Another aspect which supports the idea that Hsp90 may be involved in the ubiquitin-proteasome pathway is the discovery of a protein called carboxyl terminus of Hsp70-interacting protein (CHIP). As an E3 ubiquitin ligase | and the C-domain of Tah1. Tah1 binds to the C-terminal MEEVD motif of Hsp90 through its TPR domain. Click here to view Hop/Sti1 serves as an adaptor protein between Hsp70 and Hsp90 and facilitates the transfer of client protein. | Hsc82 and Hsp82 | belong to this group. The TPR-containing PPIases contain a PPIase domain | It was originally identified in Saccharomyces cerevisiae as a gene essential for cell cycle progression. | leading to an asymmetric Hsp90 intermediate complex. After the binding of ATP and p23/Sba1 | v-Src is an aggregation-prone protein and much more sensitive to thermal and heat denaturation than c-Src. In the case of p53 | the function of PPIases in SHR complexes is not well understood. They may be selected by specific client proteins. For example | analytical ultracentrifugation (aUC) | the Hsp90 ATPase activity is inhibited. The other TPR-acceptor site is then preferentially occupied by a PPIase | the αC-β4 loop in kinases | which consists of three TPR motifs and recognizes the C-terminal MEEVD motif in Hsp90. Besides Hop/Sti1 | and steroid hormone receptors (SHRs). | mutant CFTRΔF508 | 85747 Garching Germany Login to access the Email id Crossref citations 19 PMC citations 11 DOI: 10.4103/2319-4170.113230 PMID: 23806880 Get Permissions Abstract Heat shock protein 90 (Hsp90) is an ATP-dependent molecular chaperone which is essential in eukaryotes. It is required for the activation and stabilization of a wide variety of client proteins and many of them are involved in important cellular pathways. Since Hsp90 affects numerous physiological processes such as signal transduction | and Cyp40 (yeast homologues Cpr6/Cpr7) | Hagn et al. reported a native-like structure of p53 interaction with Hsp90. Further analysis seems to be required to resolve this conundrum and to determine the molecular mechanism for client recognition. Hsp90 and protein degradation Top Although in general | PDB 2IOQ) and nucleotide-bound yeast Hsp90 in the closed conformation (right | In the apo state | Hsp90 reaches a fully closed state in which ATP hydrolysis occurs. After ATP is hydrolyzed | and inter-domain communication. | an N-terminal ATP-binding domain (N-domain) | bacterial Hsp90 is not essential and its precise function remains to be investigated. Recent studies suggest that it collaborates with the DnaK (Hsp70) system in substrate remodeling and may function against oxidative stress. | nitrosylation | have been discovered in recent years. | neither Hsp90 nor R2TP are components of the mature snoRNP complex. The R2TP-Hsp90 complex works together with a prefoldin-like complex in RNA polymerase II assembly. This complex interacts with unassembled Rpb1 and promotes its cytoplasmic assembly and translocation to the nucleus. In addition to the activation of client protein | 85 | CK2 protein kinase | 89 | the opening of the C-domains is anti-correlated to the closing of the N-domain. A conserved MEEVD motif at the C-terminal end serves as the docking site for the interaction with co-chaperones which contain a tetratricopeptide repeat (TPR) clamp. Figure 1: Open and closed conformation of Hsp90. Crystal structures of full-length Hsp90 from E. coli (HtpG) in the open conformation (left | release ADP as well as inorganic phosphate (Pi) | a third complex that contains a PPIase and the co-chaperone p23 had been found as the last step of the cycle. | This small acidic protein contains an unstructured C-terminal tail | Hsp90 binds the largely unfolded protein. Park et al | Histindine Kinase | which seem to be in a dynamic equilibrium [Figure 1]. | Structural studies revealed that Hsp90 spontaneously adopts structurally distinct conformations | Sgt1 has no inherent Hsp90 ATPase regulatory activity due to differences in interaction. Interestingly | many others related to | nuclear migration (NudC) | Munich | like Fkbp52 | Hsp90 adopts the "closed" conformation which weakens the binding of Hop/Sti1 and therefore promotes its exit. Another PPIase or TPR co-chaperone can potentially bind to form the final complex together with Hsp90 and p23/Sba1. Following ATP hydrolysis | biochemical experiments suggest that p53 interacts with Hsp90 in a rather folded state. | the activity of Hsp90-specific clients is significantly reduced | Hsp70 and Hsp40 interact with newly synthesized kinases. Protein kinases are recruited to Hsp90 though the action of Hop/Sti1 and the kinase-specific co-chaperone Cdc37. Both are able to stabilize the Hsp90/kinase complex. Protein phosphatase Pp5 and the ATPase activator Aha1 release Hop/Sti1 from Hsp90. At a later stage | with the M-domain of Hsp90 | co-chaperones are also involved in other physiological processes | Hsp90 is a flexible dimeric protein composed of three different domains which adopt structurally distinct conformations. ATP binding triggers directionality in these conformational changes and leads to a more compact state. To achieve its function | the interaction of Cdc37 with Hsp90 leads to the stabilization of the open conformation and the inhibition of Hsp90 ATPase activity. In contrast to the co-chaperones discussed above | it is not involved in the interaction with Hsp90. Functionally | the protein phosphatase Ppt1 deletion compromised the activation of specific clients. Therefore | and a client protein form an "early complex." The client protein is transferred from Hsp70 to Hsp90 through the adaptor protein Hop/Sti1. One Hop/Sti1 bound is sufficient to stabilize the open conformation of Hsp90. The other TPR-acceptor site is preferentially occupied by a PPIase | Recent biophysical studies using ensemble and single molecule fluorescence resonance energy transfer (FRET) assays allowed to further dissect the ATP-induced conformational changes [Figure 2]. | CHIP can ubiquitinate unfolded proteins. It also interacts with the C-terminus of Hsp70 and Hsp90 through its TPR domain. | the R2TP complex (consisting of Tah1 | and a C-terminal dimerization domain (C-domain) [Figure 1]. Except for the charged linker located between the N- and M-domains in eukaryotic Hsp90 | such as formation of the active sites | several reports have shown that Hsp90 is also required for the degradation of ER membrane proteins such as cytochrome p450 2E1 | Deacetylation of Hsp90 drives the formation of Hsp90 client complexes and promotes the maturation of the client protein GR. Hsp90 can be acetylated at different sites. A study from Necker's lab pointed out that K294 | evolutionarily conserved split ATPases | Sgt1 interacts with Hsp90 as well as with an NLR protein. In the stable ternary complex | and inter-domain communications. In this review | we discuss the recent progress made in understanding the Hsp90 machinery. Keywords: ATPase | an acetylation site in the M-domain | which suggests a noncatalytic role of PPIases in the regulation of SHR signaling. In contrast to Hop/Sti1 and the TPR-PPIases | Sgt1 is promoted to interact with Hsp90 as well as with an NLR protein. In the stable ternary complex | The co-chaperone Tah1 interacts with Hsp90 through its TPR domain and its C-terminal region binds Pih1 | and electron microscopy] provided insight into how the exchange of co-chaperones is regulated. | A number of different kinases can phosphorylate Hsp90 | the N-terminal dimerization leads to the formation of the second intermediate state (I2) | it was also found to facilitate protein degradation. In addition to soluble cytosolic proteins | which leads to the final activation of protein kinases. Cdc37 is specific for chaperoning kinases. | and thus | The presence of Aha1 enables Hsp90 to bypass the I1 state and to directly reach I2 in the ATPase cycle. The activation of specific clients such as viral Src kinase (v-Src) and SHRs is severely affected in Aha1 knockout cells. Moreover | of which Hsp82 is up-regulated up to 20 times under heat stress. Hsp90α and Hsp90β are the two major isoforms in the cytoplasm of mammalian cells. Hsp90α is inducible under stress conditions | Hsp70 and Hsp40 interact with newly synthesized kinases. Protein kinases are recruited to Hsp90 through the action of Hop/Sti1 and the kinase-specific co-chaperone Cdc37. Both are able to stabilize the Hsp90/kinase complex. At a later stage | Aha1 can release Cdc37 from Hsp90 together with nucleotides. (C) Hsp90 chaperone cycle for NLRs. Rar1 binds to the N-domain of Hsp90 through its Chord1 domain and prevents the formation of the closed conformation. This interaction supports the binding of Rar1-Chord2 to the N-domain in the other protomer. With the association of Rar1-Chord2 | this domain organization is conserved from bacteria to man. Hsp90 is a member of a special class of structurally related | which is structurally similar to p23/Sba1. | called HtpG in Escherichia More Details coli | and members of the PPIase family | Mammalian Hsp90 is a target of S-nitrosylation mediated by NO produced by its client protein | Cyp40 is most abundant in estrogen receptor (ER) complexes and Fkbp52 mediates potentiation of GR through increasing GR hormone-binding affinity. Interestingly | there are two Hsp90 isoforms in the cytosol | no Hsp90 gene has been found in archea. | Johannes Buchner2 1 Division of Biology | the central player in this process | different co-chaperones work together to facilitate the maturation of Hsp90 clients. The composition of co-chaperone complexes seems to depend to some degree on the presence of a specific client protein. The chaperone cycle for SHRs Early work on Hsp90 mainly focused on the co-chaperone requirement for the activation of SHRs. | These results suggest that there may be a dynamic equilibrium between the different conformations of Hsp90 and this conformational plasticity is functionally important since it may allow Hsp90 to adapt to different client proteins. Co-chaperone regulation of Hsp90 Top Co-chaperone regulation is a conserved feature of the eukaryotic Hsp90 system. To date | which catalyzes the interconversion of the cis-trans isomerization of peptide bonds prior to proline residues and a TPR domain for the interaction with Hsp90. Most of these large PPIases show independent chaperone activity. | nuclear magnetic resonance (NMR) spectroscopy | Hsp90 does not only function in protein folding but also contribute to various cellular processes including signal transduction | which contain a Bergerat ATP-binding fold. Another interesting feature of the ATP binding region is that several conserved amino acid residues form a "lid" that closes over the nucleotide binding pocket in the ATP-bound state but is open during the ADP-bound state. The M-domain of Hsp90 is involved in ATP hydrolysis | California Institute of Technology | USA 2 Center for Integrated Protein Science | and apolipoprotein B. | innate immunity | and melanoma progression (TTC4). The above examples provide a glimpse on Hsp90 co-chaperone cycles. For some cycles | Sgt1 | Hsp90 slowly reaches the first intermediate state (I1) | is essential in eukaryotic cells. | this is not the only determinant for the interaction as other regions adjacent to the kinase domain also influence the binding to Hsp90. | Rar1 binds to the N-domain of Hsp90 through its Chord1 domain and prevents the formation of the closed conformation [Figure 3]C. This interaction supports the binding of Rar1-Chord2 to the N-domain in the other protomer. With the association of Rar1-Chord2 | Aha1 plays a critical role in the inherited misfolding disease cystic fibrosis (CF) through participating in the quality control pathway of the cystic fibrosis transmembrane conductance regulator (CFTR). Down-regulation of Aha1 could rescue the phenotype caused by misfolded CFTR. Recent research highlighted the function of Aha1 in the progression of the Hsp90 cycle. It efficiently displaces Hop/Sti1 from Hsp90 and promotes the transition from the open to closed conformation together with a PPIase in a synergistic manner. Pp5/Ppt1 is a protein phosphatase which is involved in this cycle through regulating the phosphorylation states of Cdc37. It associates with Hsp90 through its N-terminal TPR domain. Binding to Hsp90 results in the abrogation of the intrinsic inhibition of Pp5/Ppt1. Pp5/Ppt1 specifically dephosphorylates Hsp90 and Cdc37 in Hsp90 complexes. | for example | However | and Swe1Wee1 kinase. | in which the M-domain repositions and interacts with the N-domain. Then Hsp90 reaches a fully closed state in which ATP hydrolysis occurs. After ATP is hydrolyzed | Hop/Sti1 is a member of the large group of TPR co-chaperones. They contain a specialized conserved TPR-clamp domain | SHRs must pass through three complexes with different co-chaperone compositions chronologically to reach their active conformation. Hsp70/Hsp40 were identified as components in the "early complex." After association with Hsp90 through the adaptor protein Hop | and RNA modification | it became an interesting target for cancer therapy. Structurally | acetylation weakens Hsp90-client interaction | In addition to the intermediate complex | protein kinase A (PKA) | p300 was reported to be the acetyltransferase and HDAC6 acts as a deacetylase which removes the acetyl group from the protein. | Trap-1 in the mitochondrial matrix | some fundamental questions related to client proteins still remained unanswered | thus permitting access by a catalytic arginine residue of the M-domain to the ATP binding site and promoting ATP hydrolysis. Once ATP is hydrolyzed | an unstable non-TPR co-chaperone of Hsp90 [Figure 3]D. During the maturation of snoRNP | release ADP and Pi | many of them are at the same time Hsp90 client proteins. This indicates that the change of phosphorylation states of Hsp90 may influence the folding and activation of certain groups of client proteins. Acetylation Acetylation is a reversible modification mediated by opposing actions of acetyltransferases and deacetylases. Hsp90 acetylation and its influence on the chaperone machinery have been extensively investigated in recent years. In the case of Hsp90 | Hsp40 | Pasadena | and the folded client are released from Hsp90. Figure 3: Hsp90 chaperone cycles. (A) Hsp90 chaperone cycle for SHRs. Hsp70 | such as the location of the client-binding sites on Hsp90. Current evidence suggests that binding sites could be localized in each of the domains of Hsp90. Another intriguing question unsolved so far is how Hsp90 recognizes its clients. Hsp90 clients belong to different families and do not share common sequences or structural motifs. Although some regions were identified which are important for the recognition of certain group of clients | The CHIP knockdown is known to stabilize some Hsp90 clients | the ATPase activator Aha1 can release Cdc37 from Hsp90 | which is essential for its intrinsic chaperone activity. | The interaction with the Hsp90 machinery enables their correct folding | and Hsp90 returns to the open conformation. Click here to view Notably | The chaperone cycle is not completely understood yet. However | Hsp90 fails to support the activation of the client protein. Nitrosylation S-nitrosylation is a reversible covalent modification of reactive cysteine thiols in proteins by nitric oxide (NO). | Cdc37 interacts with kinases through its N-terminal domain and binds to the N-domain of Hsp90 via its C-terminal part. Similar to Hop/Sti1 | Based on these results | in which the M-domain repositions and interacts with the N-domain. Then | termed "open conformation" [Figure 1]. ATP binding triggers a series of conformational changes including repositioning of the N-terminal lid region and a dramatic change in the N-M domain orientation. Finally | endothelial nitric oxide synthase (eNOS). S-nitrosylation was reported as a negative regulator which inhibits the ATPase activity of Hsp90. In addition | p23 was identified as a component in SHR complexes | transport | we have obtained a full picture with detailed information; for others | and even degradation. | the N-domains dissociate | only phosphorylated Hsp90 stimulates the activity of the Hsp90 client protein heme-regulated inhibitor kinase (HRI); dephosphorylation eliminated the ability of Hsp90 to activate this client protein. Interestingly | the ATP hydrolysis | Hsp90 is not required for de novo folding of most proteins but facilitates the final maturation of a selected clientele of proteins. Hsp90 clients include protein kinases | the Hsp90-Tah1 complex stabilizes Pih1 in vivo and prevents its aggregation in vitro. The Tah1-Pih1 heterodimer is able to inhibit the ATPase activity of Hsp90. Tah1 and Pih1 are then transferred to the Rvb1/2 complex leading to the formation of the R2TP complex [Figure 3]D. Together | 101 | 102 | Function and Regulation of the Hsp90 Machinery Jing Li1 | termed "closed conformation" in which the N-domains are dimerized [Figure 1]. | together with nucleotides | the "intermediate complex" is formed. | p23/Sba1 and the folded client are released from Hsp90. (B) Hsp90 chaperone cycle for kinases. In the early stage | transcription factors such as p53
Journal Article
International immunopharmacology, ISSN 1567-5769, 11/2013, Volume 17, Issue 3, pp. 638 - 650
Signaling | Receptors | Inflammation | Kinases | Neutrophils | Pharmacology & Pharmacy | Immunology | Life Sciences & Biomedicine | Science & Technology | Signal Transduction - immunology | Animals | Receptors, Cell Surface - immunology | Humans | Neutrophils - immunology | Selectins - immunology | Mycoses | Lectins | Fc receptors | Integrins | Index Medicus | FcR, Fc-receptor | GPI, glycosylphosphatidylinositol anchor | CLEC, C-type lectin | OSCAR, osteoclast-associated receptor | PKB, protein kinase B | DAG, diacyl-glycerol | Tyk2, tyrosine protein kinase 2 | VCAM-1, vascular cell adhesion molecule 1 | ICAM-1, intercellular adhesion molecule 1 | FADD, Fas-associated protein with death domain | IκB, inhibitor of NF-κB | GM-CSF, granulocyte | MyD88, myeloid differentiation protein 88 | TNF, tumor necrosis factor | LTβ, lymphotoxin β | TRADD, TNFR1-associated death domain protein | Abl, Abelson leukemia proto-oncogene | SLP-76, SH2 domain-containing leukocyte protein of 76 kDa | CALDAG-GEFI, calcium and DAG-regulated guanine nucleotide exchange factor I | IL, interleukin | Src, Rous sarcoma virus proto-oncogene | IRF, IFN regulatory factor | RIG, retinoic acid-inducible gene | PLC, phospholipase C | TCR, T-cell receptor | IKK, IκB kinase | ITAM, immunoreceptor tyrosine-based activation motif | CARD, caspase activation and recruitment domain | IP3, inositol-tris-phosphate | CHO, Chinese hamster ovary cells | MKK, MAP kinase kinase | fMLP, formly-Met-Leu-Phe | TRAF, TNF receptor-associated factor | MIP, macrophage inflammatory protein | Rac, Ras-related C3 botulinum toxin substrate | monocyte colony-stimulating factor | PIP3, phosphatidylinositol-3-phosphate | VLA-4, very late antigen 4 (α4β1 integrin) | PAF, platelet activating factor | STAT, signal transducer and activator of transcription | TAK, TGFβ-activated kinase 1 | Mac-1, macrophage antigen 1 (αMβ2 integrin) | FcRγ, Fc-receptor γ-chain | Asc, apoptosis-associated speck-like protein containing a CARD | cIAP, cellular inhibitor of apoptosis | BCR, B-cell receptor | Fgr, Gardner–Rasheed feline sarcoma proto-oncogene | VASP, vasodilator-stimulated phosphoprotein | Hck, hematopoietic cell kinase | TGFβ, transforming growth factor β | Rap, Ras-related protein | SHP-1, SH2 domain-containing protein tyrosine phosphatase 1 | Syk, spleen tyrosine kinase | GPCR, G protein-coupled receptor | G-CSF, granulocyte colony-stimulating factor | TREM, triggering receptor expressed on myeloid cells | DISC, death-inducing signaling complex | MDL-1, myeloid DAP12-associating lectin 1 | C3G, Crk SH3 domain-binding guanine nucleotide exchange factor (RapGEF1) | NF-κB, nuclear factor κB | ERM, ezrin-radixin-moesin | Epac1, exchange protein activated by cyclic AMP 1 | LTB4, leukotriene B4 | Mcl, macrophage C-type lectin | SAP130, Sin3A-associated protein of 130 kDa | SH2, Src-homology 2 domain | MAP kinase, mitogen-activated protein kinase | PSGL-1, P-selectin glycoprotein ligand | PI3K, phoshoinositide-3-kinase | ADAP, adhesion and degranulation promoting adapter protein (Fyb, SLAP-130) | NLRP3, NOD-like receptor family, pyrin domain containing 3 | MDA5, melanoma differentiation-associated protein 5 | TLR, Toll-like receptor | GRK, GPCR kinase | LAD, leukocyte adhesion deficiency | MAPKAP-kinase, MAP kinase-associated protein kinase | ZAP-70, ζ-chain-associated protein of 70 kDa | TRAIL, TNF-related apoptosis-inducing ligand | JNK, c-Jun N-terminal kinase | LFA-1, lymphocyte function-associated receptor 1 (αLβ2 integrin) | ROS, reactive oxygen species | RIP3, receptor-interacting serine-threonine protein kinase 3 | DAP12, DNAX activating protein 12 | IFN, interferon | PIR, paired immunoglobulin-like receptor | PKC, protein kinase C | PAK, p21-activated kinase | ESL-1, E-selectin ligand 1 | GAP, GTPase activating protein | ERK, extracellular signal-regulated kinase | SOCS, suppressor of cytokine signaling | JAK, Janus kinase | RANK, receptor activator of NF-κB | IRAK, IL-1 receptor-associated kinase | NOD, nucleotide-binding oligomerization domain containing protein | CEACAM3, carcinoembryonic antigen-related cell adhesion molecule 3 (CD66b)
Journal Article
Biochemical journal, ISSN 0264-6021, 03/2005, Volume 386, Issue 2, pp. 201 - 214
Journal Article